MTUSD:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF USD Capitalisation (USD)

ETF | Others |

Last Closing

USD 10.7779

Change

+0.10 (+0.92)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.36 (-0.78%)

USD 64.41B
JPX4:PA Amundi Index Solutions - Amund..

-0.36 (-0.78%)

USD 64.41B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.60 (-0.12%)

USD 12.63B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.60 (-0.12%)

USD 12.63B
WRD:PA HSBC ETFs Public Limited Compa..

-0.10 (-0.31%)

USD 10.26B
WRD:PA HSBC ETFs Public Limited Compa..

-0.10 (-0.31%)

USD 10.26B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.37 (-0.96%)

USD 8.94B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.37 (-0.96%)

USD 8.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.15 (-0.03%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.15 (-0.03%)

USD 7.87B

ETFs Containing MTUSD:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.20% 36% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.20% 36% F 37% F
Trailing 12 Months  
Capital Gain 15.90% 39% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.90% 38% F 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.02% N/A N/A 36% F
Dividend Return 1.02% N/A N/A 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.05% N/A N/A 96% N/A
Risk Adjusted Return 33.57% N/A N/A 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike